INTRODUCTION {#S1}
============

The Crk family of adaptor proteins are ubiquitously expressed in most tissues and mediate the timely formation of protein complexes elicited by a variety of extracellular stimuli, including various growth and differentiation factors[@R1],[@R2]. Crk proteins are overexpressed in many human cancers[@R3]--[@R5] and were found to stimulate the activity of Abl[@R6], a kinase whose fusion to Bcr causes chronic myelogenous leukemia[@R7]. Cellular Crk (c-Crk-II) consists of a single SH2 domain, an N-terminal SH3 (SH3^N^) and a C-terminal SH3 domain (SH3^C^) ([Fig. 1a](#F1){ref-type="fig"}). The SH3^N^ and SH3^C^ domains are tethered by a 50-residue long linker, which contains a Tyr residue (Tyr222 in chicken) that becomes phosphorylated by Abl[@R8]. Crk exerts its function by using its SH2 and SH3^N^ domains, which selectively bind to pY-x-x-P and P-x-L-P-x-K motifs, respectively, to interact with a variety of proteins[@R9],[@R10]. In contrast, recent structural work on chicken[@R11] and human Crk[@R12] has shown that SH3^C^ plays an autoregulatory role, consistent with earlier biological results[@R13]--[@R16].

We have recently shown[@R11] that the binding activity of chicken Crk is modulated by *cis--trans* isomerization at Pro238, a highly conserved proline residue ([Supplementary Fig. 1](#SD1){ref-type="supplementary-material"})[@R17],[@R18]. In contrast to covalent modifications afforded by post-translational processes, proline isomerization is an intrinsic conformational exchange process that has the potential to control protein activity[@R19],[@R20] without altering the covalent structure of the protein. Proline isomerization may exert its function through multiple, non-mutually-exclusive mechanisms, involving (i) significant conformational changes caused by the 180° rotation about the prolyl bond, (ii) slow kinetics of isomerization affording a molecular timer, (iii) and the recruitment of prolyl *cis--trans* isomerase enzymes (PPIases)[@R21]. For these reasons proline *cis--trans* isomerization is emerging as a critical component of an ever increasing number of important biological processes, including cell signaling[@R11],[@R22],[@R23], neurodegeneration[@R24], amyloidogenesis[@R25], channel gating[@R26], gene regulation[@R27],[@R28], phage and virus infection[@R29],[@R30], enzyme function[@R31],[@R32], and ligand recognition[@R33]. However, despite the importance of *cis--trans* isomerization, there is a surprising paucity of high-resolution structural data elucidating the effect that this process may elicit within a protein. Thus, how proline isomerization yields a functional binary switch remains poorly understood.

Here we present high-resolution structures of both the *cis* and *trans* conformers of Pro238 in Crk. The data showed that the linker interacts extensively with the SH3^C^ domain and the interaction is strongly modulated by proline isomerization. The remarkable conformational rearrangement induced by *cis--trans* isomerization endows the conformers with distinct binding properties: in the *cis* form the two SH3 domains engage in an intramolecular fashion giving rise to an autoinhibitory conformation that prevents the binding of physiological ligands, such as the Abl kinase; in contrast, in the *trans* form the two SH3 domains do not interact and Crk exists in a uninhibited, ligand-binding-competent conformation. Interestingly, all of these interactions are mediated by novel SH3 binding surfaces. The results (i) provide unprecedented insight into the drastic, long-range conformational effect that proline isomerization may elicit constituting an elegant mechanism for protein activity regulation and (ii) highlight the versatile and unique binding properties of the SH3 modular domain.

RESULTS {#S2}
=======

Structure of the *trans* and *cis* conformers of Crk {#S3}
----------------------------------------------------

We have previously shown[@R11] that Pro238 in Crk undergoes *cis--trans* isomerization ([Fig. 1](#F1){ref-type="fig"}) giving rise to two distinct, equally populated conformational states of the linker-SH3^C^ (l-SH3^C^) polypeptide ([Supplementary Fig. 2a](#SD1){ref-type="supplementary-material"}). Because of the intrinsically high activation energy for rotation about the prolyl bond (\~20 kcal mol^−1^)[@R17], the two conformational states interconvert at a very slow rate. Moreover, the *cis* and *trans* conformers in Crk l-SH3^C^ are equally populated (\~50% each; [Supplementary Fig. 2a](#SD1){ref-type="supplementary-material"}). These favorable conditions enabled the complete NMR characterization and structure determination of both conformers ([Fig. 2](#F2){ref-type="fig"} and [Supplementary Fig. 3 and Supplementary Methods](#SD1){ref-type="supplementary-material"}).

Pro isomerization modulates intramolecular interactions {#S4}
-------------------------------------------------------

The lowest-energy structure of the *trans* and *cis* conformers of l-SH3^C^ are displayed in [Figure 2a,b](#F2){ref-type="fig"}. In both conformers the SH3^C^ domain adopts a typical SH3 fold; however, because of the lack of aromatic residues at its canonical binding site, SH3^C^ does not bind polyproline II (PPII)-type sequences[@R13],[@R34]. Superposition of the structures of the *cis* and *trans* conformers showed that isomerization about the Gly237--Pro238 prolyl bond results in notably distinct conformations of the linker with respect to SH3^C^ ([Fig. 3a](#F3){ref-type="fig"}). In the *trans* form the SH3^C^ n-src loop adopts a typical conformation seen in the majority of the SH3 domains. However, in the *cis* form the n-src loop rearranges significantly to accommodate the linker, which, as a result of the *cis* conformation adopted by the Gly237--Pro238 prolyl bond, is forced further closer to SH3^C^ ([Fig. 3a,b](#F3){ref-type="fig"}). Interestingly, SH3^C^ uses the same surface to interact with the linker in both the *cis* and *trans* conformers but distinct sets of interactions stabilize them.

The interaction of the linker with SH3^C^ in the *trans* conformer is mediated primarily by hydrophobic contacts. More specifically, Ala223, Ile227, Pro230 and Pro232 at the linker interact with Phe239, Lys269, Ile270, Asn271, Trp276, and Leu294 at SH3^C^ ([Fig. 2b](#F2){ref-type="fig"}). The linker--SH3^C^ interaction is further enhanced by hydrogen bonds formed between Asn233 and Lys269 and between Asn236 and Gln297. Overall, the linker--SH3^C^ interaction buries a remarkable \~1,150 Å^2^ of surface ([Supplementary Fig. 4a](#SD1){ref-type="supplementary-material"}). The last 10 C-terminal residues of the linker (Ile227 to Asn236) interact intimately with the SH3^C^ domain. In contrast, residues preceding Ile227, other than Ala223, do not appear to form strong and persistent contacts with SH3^C^, an observation that is further corroborated by NMR relaxation analysis showing that indeed the N-terminal linker residues are very flexible on the fast (pico-to-nanosecond, ps-ns) time scale (see below).

In contrast to the *trans* conformer, the linker--SH3^C^ interaction in the *cis* conformer is mediated exclusively by hydrophobic contacts ([Fig. 2d](#F2){ref-type="fig"}). In fact, only three residues from the linker (Pro230, Leu231, and Leu234) interact with SH3^C^ ([Fig. 2d](#F2){ref-type="fig"} and [Supplementary Fig. 4b](#SD1){ref-type="supplementary-material"}). Nevertheless, the linker--SH3^C^ interaction in the *cis* conformer buries \~1,140 Å^2^ of surface, which equals the amount of surface buried in the *trans* conformer. The reason being that in the *cis* conformer the N-terminal part of the linker (residues Pro221 to Ile227) folds over and packs against the C-terminal part of the linker (residues Pro230 to Asn236) ([Supplementary Fig. 5](#SD1){ref-type="supplementary-material"}). Whereas in the *trans* conformer Pro230 and Pro232 are facing and interact with SH3^C^ ([Fig. 2b](#F2){ref-type="fig"}), in the *cis* conformer these two Pro residues form a hydrophobic pocket facing the linker with Pro225 and Ile227 fitting snugly into it ([Supplementary Fig. 5](#SD1){ref-type="supplementary-material"}). Interestingly, in the *cis* conformer the side chain of Leu231 is completely buried into a hydrophobic pocket in SH3^C^ lined by residues Ala241, Val267, Trp276, Phe289, and Val292 ([Fig. 3c](#F3){ref-type="fig"}). The strong linker--SH3^C^ hydrophobic contacts result in significant stabilization of the interface and thus of the *cis* conformer, which is equally populated to the *trans* conformer.

Malleability of the SH3^C^ surface {#S5}
----------------------------------

Prolyl *cis--trans* isomerization at Pro238 results in a large conformational rearrangement of the linker in the two conformers ([Fig. 3a](#F3){ref-type="fig"}). As a consequence, the linker presents an entirely different surface to SH3^C^ for binding. Notably, the SH3^C^ surface that interacts with the linker adjusts drastically between the *cis* and *trans* conformers in order to optimize binding contacts with the alternative linker conformations ([Fig. 3b](#F3){ref-type="fig"}). The SH3^C^ n-src loop undergoes the most significant conformational change between the *cis* and *trans* conformers with a maximum translation of \~8 Å ([Fig. 3b](#F3){ref-type="fig"}). As a result, many of the n-src and neighboring side chains rearrange, with notable examples being residues Phe239, Trp276, Phe289 and Ile270. In the *trans* conformer, the linker residues Ile227, Pro230 and Pro232 mediate all of the hydrophobic contacts with SH3^C^. In the *cis* conformer, Ile227 and Pro232 swing out of the linker--SH3^C^ interface ([Fig. 2b,c](#F2){ref-type="fig"} and [3a](#F3){ref-type="fig"}) in order to form, together with Pro230 and Pro225, a hydrophobic core within the linker ([Supplementary Fig. 5](#SD1){ref-type="supplementary-material"}). To compensate for the loss of these linker--SH3^C^ hydrophobic contacts, as well as for the complete lack of polar interactions, the linker in the *cis* conformer uses Leu231 to interact firmly with SH3^C^ ([Fig. 3c](#F3){ref-type="fig"}). Ile270, Trp276 and Phe289 of SH3^C^ adjust their side chain conformation to form a deep hydrophobic pocket wherein Leu231 side chain enters into and completely buries itself ([Fig. 3c](#F3){ref-type="fig"} and **Supplementary Movie**). Interestingly, the conformation adopted by Phe239 in the *trans* conformer is not compatible with Leu231 binding to the deep pocket and as result of the *trans*-to-*cis* isomerization Phe239 is expelled from the interior of the protein (*trans*) to become completely solvent exposed (*cis*) ([Fig. 3b,c](#F3){ref-type="fig"}). The drastically different SH3^C^ and linker conformations induced by *cis--trans* isomerization give rise to distinct surfaces of the l-SH3^C^, potentially conferring the two conformers with distinct binding and physicochemical properties ([Fig. 3d,e](#F3){ref-type="fig"}).

Dynamic changes caused by *cis--trans* isomerization {#S6}
----------------------------------------------------

*Cis--trans* isomerization causes a drastic structural change in both the linker and the SH3^C^ domain. Does the isomerization process also bring about changes in the dynamics of the protein? To address this question we measured backbone relaxation rates[@R35],[@R36] to obtain site-specific information about the N-H bond order parameters ([Supplementary Fig. 6](#SD1){ref-type="supplementary-material"}). The order parameter, S^2^, is a measure of the amplitude of internal motions on the pico-to-nanosecond (ps-ns) timescale and may vary from S^2^=1, for a bond vector having no internal motion, to S^2^=0, for a bond vector rapidly sampling multiple orientations[@R36].

*Cis--trans* isomerization at Pro238 results in significant changes in S^2^ throughout Crk l-SH3^C^ ([Fig. 4](#F4){ref-type="fig"}). In the region around Pro238 there is significant enhancement in the flexibility on going from the *trans* to the *cis* isomer presumably as a result of the increase in solvent exposure of Phe239 ([Fig. 4](#F4){ref-type="fig"}). A similar trend was also seen for the region around Ile270 for the same reason. In contrast, *trans-to-cis* isomerization causes significant rigidification in the linker, especially nearby Leu231, the residue that is completely buried into a hydrophobic pocket in the SH3^C^ domain in the *cis* isomer ([Fig. 3c](#F3){ref-type="fig"}). Moreover, there is significant rigidification in most of the n-src loop as a result of the tighter packing between this loop and the linker. In addition, most of the linker residues appear to be slightly more rigid in the *cis* conformer than in the *trans* one primarily because of the improved packing within the linker in the *cis* conformer ([Supplementary Fig. 5](#SD1){ref-type="supplementary-material"}). Thus, the data indicate that *cis--trans* isomerization causes not only significant structural changes ([Fig. 2](#F2){ref-type="fig"},[3](#F3){ref-type="fig"}) but also significant changes in the motions of the protein ([Fig. 4](#F4){ref-type="fig"}).

Structural basis for the SH3^N^--SH3^C^ interaction {#S7}
---------------------------------------------------

Combined chemical shift and relaxation rate analyses have indicated[@R11] that Crk SH3^N^-linker-SH3^C^ (Crk^SLS^) ([Fig. 1a](#F1){ref-type="fig"}) exists in two conformations in solution: a major one (90%), wherein Gly237--Pro238 adopts the *cis* conformation and the two SH3 domains (SH3^N^ and SH3^C^) interact in an intramolecular fashion (closed conformation), and a minor one (10%), wherein Gly237--Pro238 adopts the *trans* conformation and the two SH3 domains do not interact (open conformation) ([Supplementary Fig. 7](#SD1){ref-type="supplementary-material"}). NMR analysis shows that the full-length chicken Crk adopts a similar closed conformation. We now provide atomic insight into this very interesting binding process by having determined the structure of the closed conformation of Crk^SLS^ ([Fig. 5a](#F5){ref-type="fig"} and [Supplementary Fig. 3c](#SD1){ref-type="supplementary-material"}).

The structural data showed, in agreement with the chemical shift analysis data, that the two SH3 domains interact extensively in the closed Crk^SLS^ ([Fig. 5a](#F5){ref-type="fig"}). The SH3^N^ domain uses its canonical binding site, typically interacting with PPII ligands, to interact with SH3^C^. Specifically, a cluster of SH3^N^ aromatic residues (Phe142, Phe144, Trp170 and Tyr187) along with Pro184 and Pro186 form an elongated hydrophobic solvent-exposed surface comprising its canonical ligand-binding site ([Fig. 5b](#F5){ref-type="fig"}). This site is well suited to interact with hydrophobic sequences, such as proline-rich sequences. In Crk, SH3^C^ uses the hydrophobic residues Pro238, Phe239 and Ile270 to interact with the canonical binding-site of SH3^N^ ([Fig. 5b,c](#F5){ref-type="fig"}). The interaction is further enhanced by the formation of two polar contacts: a hydrogen bond between Gln169 and Lys266 and a salt bridge between Asp143 and Lys269. Overall, the SH3^N^--SH3^C^ interaction buries a total surface of \~800 Å^2^.

The Crk SH3^N^ domain binds selectively to PPII ligands carrying the P-x-L-P-x-K sequence motif[@R37] ([Fig. 5d](#F5){ref-type="fig"}), such as the Abl kinase[@R38]. Pro1, Leu3 and Pro4 residues of the PPII ligand are closely packed against the hydrophobic residues in SH3^N^, whereas Lys6 forms salt bridges with conserved acidic residues[@R10] ([Fig. 5d](#F5){ref-type="fig"}). SH3^C^ uses a similar set of interactions to bind specifically to SH3^N^: Pro238 and Phe239 of SH3^C^ occupy similar positions, relative to SH3^N^, to Pro4 and Leu3, respectively, of the PPII peptide. Gln297, which forms a hydrogen-bond to SH3^N^, is found in a similar position to Lys6 of the PPII peptide, whereas Lys269 forms a salt-bridge to Asp143 ([Fig. 5b](#F5){ref-type="fig"}), a highly conserved residue that does not participate though in the interaction between SH3^N^ and the PPII peptide ([Fig. 5d](#F5){ref-type="fig"}). Interestingly, the juxtaposition of SH3^N^ with the PPII ligand appears to be more optimal than with SH3^C^ since complex formation buries \~1,120 Å^2^ in the first case but only \~800 Å^2^ in the latter. The rather small interface between SH3^N^ and SH3^C^ is consistent with the low free energy (ΔG) of SH3^N^--SH3^C^ interaction, which is only \~1.4 kcal mol^−1^ ([Supplementary Fig. 7b](#SD1){ref-type="supplementary-material"}).

The SH3^N^--SH3^C^ interaction is mediated by the *cis* conformer {#S8}
-----------------------------------------------------------------

Analysis of the closed Crk^SLS^ structure showed that Pro238 adopts uniquely the *cis* conformation. Interestingly, Pro238 adopts the *trans* conformation in the minor, open conformation of Crk^SLS^. Thus, in agreement with our previous chemical shift analysis ([Supplementary Fig. 7a](#SD1){ref-type="supplementary-material"})[@R11], the structural data demonstrated that the intramolecular interaction between the two SH3 domains is mediated exclusively by the *cis* conformer. The present data provide now the structural basis for this observation. [Figure 6a](#F6){ref-type="fig"} displays the overlay of the structures of Crk^SLS^ and the *cis* and *trans* conformers of l-SH3^C^ superimposed on the SH3^C^ domain. The SH3^N^--SH3^C^ interaction is primarily mediated by SH3^C^ residues Pro238, Phe239, and Ile270. The structural data clearly show that all these three residues are well poised to interact with the SH3^N^ domain in the *cis* conformer. In contrast, in the *trans* conformer Phe239 is located in the interior of the SH3^C^ domain and Ile270 swings towards the center of the SH3^C^ domain as a result of the drastic rearrangement that n-src loop undergoes triggered by *cis--trans* isomerization ([Fig. 3b](#F3){ref-type="fig"} and [6a](#F6){ref-type="fig"}). Thus, neither Phe239 nor Ile270 are poised to interact with the SH3^N^ domain in the *trans* conformation (**Supplementary Movie**).

Phe239 undergoes the most dramatic conformational change upon *cis--trans* isomerization ([Fig. 3b](#F3){ref-type="fig"} and [6a](#F6){ref-type="fig"}) and seems to play a key role in mediating SH3^N^--SH3^C^ binding. Indeed, substitution of Phe239 by Ala abolishes the intramolecular interaction and Crk^SLS^-F239A adopts predominantly the open conformation ([Fig. 6b](#F6){ref-type="fig"} and [Supplementary Fig. 8](#SD1){ref-type="supplementary-material"}). Similarly, the P238A substitution also abrogates the closed conformation ([Fig. 6b](#F6){ref-type="fig"}). To test the effect of destabilizing the *cis* conformation on the integrity of the closed conformation we prepared and characterized substitutions of Pro232 and Leu231, two residues that are important for stabilizing the *cis* conformer through hydrophobic interactions ([Supplementary Fig. 5](#SD1){ref-type="supplementary-material"}). Indeed, the P232A substitution decreases the stability of the closed conformation of Crk^SLS^ by \~1.1 kcal mol^−1^, whereas the L231G substitution appears to completely abrogate the closed conformation ([Fig. 6b](#F6){ref-type="fig"} and [Supplementary Fig. 8](#SD1){ref-type="supplementary-material"}). Interestingly, Pro238 is compatible with SH3^N^ binding in both the *cis* and *trans* conformations ([Fig. 6a](#F6){ref-type="fig"}). Therefore, prolyl isomerization does not regulate binding specificity directly by means of the actual conformation of the proline itself, but rather indirectly by "sculpturing" the SH3^C^ surface responsible for binding to SH3^N^.

The SH3^N^--SH3^C^ interaction results in Crk autoinhibition {#S9}
------------------------------------------------------------

Previous experiments have shown that the binding of PPII peptides to the SH3^N^ domain in Crk is much weaker compared to the binding of the PPII ligand to the isolated SH3^N^ domain[@R11]. The present data provide the structural basis for the inhibition. SH3^C^ binds to SH3^N^ and masks the canonical PPII-binding site thereby providing an autoregulatory mechanism. Indeed, Abl kinase, which interacts with Crk SH3^N^ through a P-x-L-P-x-K sequence motif, binds to the closed, autoinhibited form of Crk^SLS^ with a 10-fold lower affinity than to the open form of Crk^SLS^, induced by the F239A substitution ([Supplementary Fig. 9](#SD1){ref-type="supplementary-material"}). Thus, ligand binding to Crk is inhibited in the *cis* form but it is promoted in the *trans* form.

Novel SH3 binding surfaces {#S10}
--------------------------

The linker--SH3^C^ and SH3^N^--SH3^C^ interactions are mediated by a novel set of SH3 surfaces and contacts not seen previously in SH3 domains. Specifically, the linker interacts extensively with a surface of the SH3^C^ domain delineated by β-strands a and e and the n-src loop ([Supplementary Fig. 10](#SD1){ref-type="supplementary-material"}). Notably, the linker interacts with this SH3^C^ surface in both the *cis* and *trans* conformers, although a distinct set of contacts stabilize the two conformations. The interaction is quite extensive as it buries \~1,150 Å^2^ of surface. Moreover, SH3^C^ uses a novel binding surface to interact with the other SH3 domain in Crk, SH3^N^ ([Supplementary Fig. 10](#SD1){ref-type="supplementary-material"}). The two surfaces are distinct and not mutually exclusive since in the closed form of Crk^SLS^ SH3^C^ is bound to both the linker and SH3^N^ simultaneously. Thus, the present data further highlight the binding versatility of SH3 domains and expands the list of the non-canonical ligands that may interact with this small signaling domain.

DISCUSSION {#S11}
==========

Proline *cis--trans* isomerization is an emerging regulatory mechanism involved in the activity regulation of a wide range of biomolecular processes. Understanding the underlying mechanisms of such molecular switches necessitates the availability of structural data on both the *cis* and *trans* conformers. The limited structural information[@R19],[@R20],[@R39] on both conformers available so far has been suggestive of a rather local effect caused by proline isomerization. Here we provide atomic details of the structural and dynamic changes elicited by proline *cis--trans* isomerization in the Crk signaling protein. The data demonstrate that proline isomerization causes a remarkable reorganization of the interface between the linker and the SH3^C^ domain, to the extent that the two resultant conformers present drastically different surfaces ([Fig. 3d,e](#F3){ref-type="fig"}). Notably, the two conformers are conferred with distinct binding properties, with the *cis* one promoting the intramolecular engagement of the two SH3 domains to assemble an autoregulatory conformation and the *trans* conformer promoting a dumbbell-like, uninhibited conformation (**Supplementary Movie**).

How can a 180° rotation about a single prolyl bond cause such a strong effect on the global structure of the protein? Pro238 in Crk is located at a strategic position where the linker connects to the SH3^C^ domain. In the *trans* conformer the linker interacts extensively with the SH3^C^ domain. *Trans-to-cis* isomerization at Pro238 forces a new conformation to the linker thereby disrupting all contacts between the linker and the SH3^C^ present in the *trans* form. Notably, both the linker and the SH3^C^ domain readjust their structure and a new set of contacts is formed to stabilize the *cis* conformer. As a result, the SH3^C^ domain exposes several residues that form a binding surface capable of mediating the specific interaction between SH3^C^ and SH3^N^ ([Fig. 6a](#F6){ref-type="fig"} and **Supplementary Movie**). In the *trans* form this set of residues is buried and thus the SH3^N^-SH3^C^ interaction is not possible resulting in a dumbbell-like conformation. Thus, the structural basis for the function of Pro238 as a molecular switch is the surface "sculpturing" afforded by the actual isomerization process.

The proline switch in Crk plays a very important physiological role as it toggles the protein between a closed and an open conformation ([Fig. 7](#F7){ref-type="fig"}). In fact, the open conformation, which is lowly populated (\~10%), constitutes the activated form of Crk wherein the PPII-binding site is accessible to physiological ligands. Indeed, Abl binds preferentially to the open form of Crk ([Supplementary Fig. 9](#SD1){ref-type="supplementary-material"})[@R11]. The energetics of the equilibrium between the auto-inhibited and the activated form is regulated by the proline switch since only the *cis* isomer stabilizes the closed form. However, proline isomerization is intrinsically a very slow process (of the order of minutes) rendering the kinetics of the molecular switch particularly slow ([Fig. 7](#F7){ref-type="fig"}). Interestingly, cyclophilin A (CypA) accelerates dramatically the rate of the interconversion[@R11], to the millisecond regime at physiological temperatures, a more meaningful timescale for modulating the kinetics of biological processes. Thus, proline isomerization in Crk functions as a molecular timer whereby the energetics and rate of signaling complexes formation can be regulated.

To what extent this regulatory mechanism is shared by other Crk family members remains to be addressed. Pro238 is strictly conserved among all Crk proteins ([Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}) raising the possibility that proline isomerization may be a conserved feature. Interestingly, our data also indicate that the identity of the residue following the proline determines the population of the *cis* form. For example, the F239A substitution decreases the *cis* population to \~8%, from 50% in the wild type protein. This position is variable among Crk proteins ([Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}). Thus, it is possible that proline isomerization is present in other Crk proteins although the relative population of the two conformers may not be as high as in chicken Crk. Interestingly, tyrosine (Tyr222) phosphorylation[@R40] and the presence of an Abl SH3 binding site within the Crk SH2 domain[@R41] provide additional regulatory mechanisms of Crk activity. It is intriguing that multiple layers of regulation are present in an adaptor protein, and it will be important to determine the relative contribution of each one of these mechanisms in modulating the response of Crk to different stimuli.

The present results, in agreement with previous observations[@R11],[@R12], highlight the importance of the SH3^C^ domain in establishing and stabilizing the auto-inhibitory conformation in Crk. Point mutations or deletions in the SH3^C^ domain were shown to stimulate the transforming activity of Crk[@R6],[@R13],[@R16] and increase its expression levels in malignant brain and lung tumors[@R3]. For example, v-Crk, the viral oncogenic form of Crk that was originally isolated as an avian sarcoma virus in chicken tumors[@R42], and c-Crk-I, an alternative splicing cellular form, lack the SH3^C^ domain and the linker and they are associated with increased transforming activity[@R12] that cannot be controlled. Even single point mutations in the SH3^C^ domain (e.g. W276K) known to disrupt the folding of the domain are sufficient to significantly increase Crk activity[@R43]. Interestingly, structural studies on human Crk[@R12] and chicken Crk (this work) show that in both cases the SH3^N^ domain is autoinhibited but different structural elements are responsible for blocking the PPII-ligand binding site ([Supplementary Fig. 11](#SD1){ref-type="supplementary-material"}).

A particularly striking result in the present work is related to the versatility of the SH3 domain as a binding partner[@R44],[@R45]. The interaction between SH3^N^ and SH3^C^ in Crk provides the first example of an SH3--SH3 complex mediated by direct contacts between the two domains. Moreover, the surfaces used by SH3^C^ to interact with the linker and SH3^N^ are novel binding surfaces for SH3 domains. It is remarkable that almost the entire surface ([Supplementary Fig. 10](#SD1){ref-type="supplementary-material"}) of such a small domain can be molded to accommodate a wide range of ligands with no apparent sequence or structure similarity.

METHODS {#S12}
=======

Protein preparation {#S13}
-------------------

The following Crk (chicken) constructs were used: full-length Crk (residues 1--305), Crk^SLS^ (residues 139--305), and l-SH3^C^ (residues 218--305). The various Crk constructs were amplified by PCR, using as a template the plasmid that encodes the full-length Crk protein, inserted into the pGEX6P-1 vector engineered with a PreScission protease cleavage site and transformed into BL21(DE3) cells. NMR samples were prepared as described in [Supplementary Information](#SD1){ref-type="supplementary-material"}.

NMR spectroscopy {#S14}
----------------

NMR experiments were performed on Varian 800- and 600-MHz and Bruker 700- and 600-MHz spectrometers. Complete backbone and side-chain assignment for the Crk proteins studied was achieved using standard triple-resonance pulse sequences. NOEs were measured using 2D and 3D NOESY (^13^C and ^15^N edited) experiments using mixing times of 80 and 100 ms. All NMR samples were prepared in 50 mM KPi (pH 5.5), 140 mM NaCl, 1 mM DTT and 1 g l^−1^ NaN~3~. Pro238 isomerization as well as the relative population of the isomers are not sensitive to pH within the range 5.5--7.5 ([Supplementary Fig. 12](#SD1){ref-type="supplementary-material"}). Concentration of proteins was 0.6--0.8 mM. Spectra were recorded at 22 °C. RDC data[@R46] were collected and analyzed[@R47] as detailed in [Supplementary Information](#SD1){ref-type="supplementary-material"}.

Structure calculation and refinement {#S15}
------------------------------------

Structure calculations were performed with Xplor-NIH[@R48]. The ^13^Cα, ^13^Cβ, ^13^C\', Hα, ^15^N and NH chemical shifts served as input for the TALOS program[@R49] to extract dihedral (φ and ψ) angles. Distance restraints derived from the NOESY spectra were categorized in 3 bins with upper-bound distances of 2.8, 3.5, and 5.0 Å. RDC restraints were included in the final stages of the calculation. Ramachandran statistics for *cis* l-SH3^C^, *trans* l-SH3^C^, and Crk^SLS^, respectively, are as follows: residues in most favored regions: 71, 66, and 65; residues in additionally allowed regions: 26, 32, and 29; residues in generously allowed regions: 3, 2, and 6; residues in disallowed regions: 0, 0, and 0. The summary of NMR restraints and structure refinement statistics is presented in [Supplementary Table 1](#SD1){ref-type="supplementary-material"}.

Relaxation {#S16}
----------

Three relaxation parameters were measured for all backbone amides of Crk proteins: the ^1^H-^15^N NOE, the longitudinal relaxation rate R~1~ and the transverse relaxation rate R~2~[@R50]. Details are provided in [Supplementary Information](#SD1){ref-type="supplementary-material"}.

ITC experiments {#S17}
---------------

Calorimetric titrations were performed on an iTC200 microcalorimeter (Microcal) as described in detail in [Supplementary Information](#SD1){ref-type="supplementary-material"}.

Accession codes {#S18}
---------------

Protein Data Bank: Coordinates for the *cis* and *trans* conformers of l-SH3^C^ and Crk^SLS^ have been deposited with accession codes 2L3P, 2L3Q, and 2L3S, respectively.
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![Domain organization of Crk\
**(a)** Schematic diagram of the domain organization of Crk. Pro238, which undergoes *cis--trans* isomerization, and the tyrosine residue (Tyr222) that becomes phosphorylated by Abl are indicated. **(b)** Schematic of *cis--trans* isomerization about the prolyl Gly237--Pro238 bond.](nihms-257930-f0001){#F1}

![Structural characterization of the *trans* and *cis* Crk l-SH3^C^ conformers\
**(a,b)** Structure of the Crk l-SH3^C^ polypeptide in the *trans* conformation and **(c,d)** in the *cis* conformation. In (a and c) the SH3^C^ domain is colored light blue and the linker is colored grey. Pro238 is shown in red. N and C denote the N- and C-terminus. In (b and d) the SH3^C^ domain is displayed as a semi-transparent surface and residues involved in the linker--SH3^C^ interactions are highlighted. Linker and SH3^C^ residues are colored green and yellow, respectively. Dotted lines denote hydrogen bonding.](nihms-257930-f0002){#F2}

![Structural comparison of the *trans* and *cis* isomers\
**(a)** Superposition of the *trans* and *cis* conformers of l-SH3^C^ on the SH3^C^ domain (residues 239--295). The SH3^C^ domain in the *trans* and *cis* conformation is in light and dark grey, respectively. The linker adopts a very different structure in the *trans* (green) and the *cis* (purple) conformation. Representative residues at the linker are indicated. The conformation of the n-src loop is distinct in the *trans* (green) and the *cis* (purple) conformer. **(b)** Effect of *cis--trans* isomerization on the structure of SH3^C^. The side-chain conformation of select residues is shown. The side chain of Phe239 is solvent exposed in the *cis* isomer (purple) whereas it is buried in the *trans* isomer (green). Superposition of the structures and color code are as in (a). **(c)** Leu231 is completely buried into a hydrophobic pocket in SH3^C^ in the *cis* conformation. The side-chain conformation of residues lining the hydrophobic pocket is shown in the *cis* (purple) and *trans* (green) isomers.**(d,e)** Solvent-accessible surface presentation of the *trans* (d) and *cis* (e) conformations. The models are rotated \~60° about the z axis relative to the models in (a) with the linker facing the reader. The surface presented by the linker is delineated.](nihms-257930-f0003){#F3}

![Dynamic characterization of the *trans* and *cis* isomers\
**(a)** N-H bond order parameters, S^2^, plotted as a function of the primary sequence, for the *trans* (blue) and *cis* (red) conformers of l-SH3^C^. **(b)** Changes in order parameters, ΔS^2^, between the *trans* and the *cis* conformers mapped using a gradient color code on the structure of *cis* l-SH3^C^. ΔS^2^ is given as S^2^ (*trans*) -- S^2^ (*cis*), so positive ΔS^2^ values denote enhanced rigidity of the protein backbone in the *trans* over the *cis* conformation.](nihms-257930-f0004){#F4}

![Structural characterization of Crk^SLS^ in the closed, autoinhibited conformation\
**(a)** Lowest-energy structure of Crk^SLS^ shown as cartoon with SH3^N^ in pink, SH3^C^ in light blue, and linker in grey. **(b)** Close-up view of the SH3^N^--SH3^C^ interface. SH3^N^ and SH3^C^ residues are colored green and orange, respectively. **(c)** View from above SH3^C^, which is shown as transparent blue cartoon. SH3^N^ is displayed as pink solvent-accessible surface. SH3^C^ residues interacting with SH3^N^ are shown as orange sticks. **(d)** Structure of SH3^N^ in complex with a consensus PPII peptide (P-x-P-L-x-K)[@R10]. The orientation of SH3^N^ in (c) and (d) is the same. Comparison of (c) and (d) show that the PPII-binding site in Crk^SLS^ is not accessible.](nihms-257930-f0005){#F5}

![Structural basis for conformer-specific SH3^N^--SH3^C^ interaction in Crk^SLS^\
**(a)** Superposition of the cis and *trans* l-SH3^C^ and Crk^SLS^ on the SH3^C^ domain. The side chains of Pro238, Phe239, and Ile270, residues primarily mediating the SH3^N^--SH3^C^ interaction, are shown in green for *trans* and yellow for *cis* l-SH3^C^ and orange for Crk^SLS^. SH3^N^ is shown as solvent-accessible surface. **(b)** Effect of single amino acid substitution on the stability of the closed conformation of Crk^SLS^ as assessed by measuring the population of the closed and open conformations of Crk^SLS^ by NMR. ΔG for P238A and L231G is a lower-bound limit since populations less than \~5% are beyond the NMR detection limit.](nihms-257930-f0006){#F6}

![Mechanistic basis for the the regulation of Crk activity\
Crk adopts predominantly (\~90%) the closed, auto-inhibited conformation but a minor population (\~10%) adopts the open, uninhibited conformation wherein the PPII-binding site on SH3^N^ is accessible for binding. The P-x-L-P-x-K motif of Abl binds to SH3^N^ with a relatively strong affinity (K~d~ \~1 μM). The open conformation exists as an equilibrium between the *cis* and the *trans* isomer, but only the *cis* one forms the closed conformation. The rates of the *cis--trans* interconversion are regulated by the action of CypA, which accelerates the interconversion by four orders of magnitude[@R11].](nihms-257930-f0007){#F7}
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